Display options
Cite
Yadavilli S, Hwang EI, Packer RJ, et al. The Role of NG2 Proteoglycan in Glioma. Transl Oncol. 2016;9(1):57-63doi: 10.1016/j.tranon.2015.12.005.
Yadavilli, S., Hwang, E. I., Packer, R. J., & Nazarian, J. (2016). The Role of NG2 Proteoglycan in Glioma. Translational oncology, 9(1), 57-63. https://doi.org/10.1016/j.tranon.2015.12.005
Yadavilli, Sridevi, et al. "The Role of NG2 Proteoglycan in Glioma." Translational oncology vol. 9,1 (2016): 57-63. doi: https://doi.org/10.1016/j.tranon.2015.12.005
Yadavilli S, Hwang EI, Packer RJ, Nazarian J. The Role of NG2 Proteoglycan in Glioma. Transl Oncol. 2016 Feb;9(1):57-63. doi: 10.1016/j.tranon.2015.12.005. PMID: 26947882; PMCID: PMC4800061.
Copy Download .nbib Format: NLM
Share it on

Transl Oncol. 2016 Feb;9(1):57-63. doi: 10.1016/j.tranon.2015.12.005.

The Role of NG2 Proteoglycan in Glioma.

Translational oncology

Sridevi Yadavilli, Eugene I Hwang, Roger J Packer, Javad Nazarian

Affiliations

  1. Research Center for Genetic Medicine, Children's National Health System, 111 Michigan Ave. NW, Washington, DC 20010, USA.
  2. Division of Oncology, Children's National Health System, 111 Michigan Ave. NW, Washington, DC 20010, USA.
  3. Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC 20010, USA.
  4. Research Center for Genetic Medicine, Children's National Health System, 111 Michigan Ave. NW, Washington, DC 20010, USA; Department of Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington, DC 20052, USA. Electronic address: [email protected].

PMID: 26947882 PMCID: PMC4800061 DOI: 10.1016/j.tranon.2015.12.005

Abstract

Neuron glia antigen-2 ((NG2), also known as chondroitin sulphate proteoglycan 4, or melanoma-associated chondroitin sulfate proteoglycan) is a type-1 membrane protein expressed by many central nervous system (CNS) cells during development and differentiation and plays a critical role in proliferation and angiogenesis. 'NG2' often references either the protein itself or the highly proliferative and undifferentiated glial cells expressing high levels of NG2 protein. NG2 glia represent the fourth major type of neuroglia in the mammalian nervous system and are classified as oligodendrocyte progenitor cells by virtue of their committed oligodendrocyte generation in developing and adult brain. Here, we discuss NG2 glial cells as well as NG2 protein and its expression and role with regards to CNS neoplasms as well as its potential as a therapeutic target for treating childhood CNS cancers.

Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

References

  1. FEBS J. 2013 May;280(10):2399-417 - PubMed
  2. Curr Biol. 2002 Jul 9;12(13):1157-63 - PubMed
  3. J Biol Chem. 1999 Jun 11;274(24):16831-7 - PubMed
  4. Microvasc Res. 2002 Jan;63(1):129-34 - PubMed
  5. Neuroimage. 2006 Feb 1;29(3):965-76 - PubMed
  6. Genesis. 2000 Nov-Dec;28(3-4):147-55 - PubMed
  7. Mol Biol Cell. 2004 Aug;15(8):3580-90 - PubMed
  8. Oncogene. 2008 Sep 4;27(39):5182-94 - PubMed
  9. J Anat. 2005 Dec;207(6):727-34 - PubMed
  10. Adv Cancer Res. 2010;109:73-121 - PubMed
  11. J Neurosci. 1998 Oct 1 ;18(19):7709-16 - PubMed
  12. PLoS One. 2013 Dec 26;8(12):e84883 - PubMed
  13. Exp Cell Res. 1997 Aug 25;235(1):254-64 - PubMed
  14. J Biol Chem. 2008 Mar 28;283(13):8310-7 - PubMed
  15. Neuroscience. 1999;92(1):83-95 - PubMed
  16. Development. 2011 Feb;138(4):745-53 - PubMed
  17. Brain Res. 2016 May 1;1638(Pt B):183-98 - PubMed
  18. Neuron Glia Biol. 2008 Feb;4(1):19-26 - PubMed
  19. Science. 2001 Jan 26;291(5504):657-61 - PubMed
  20. Dev Dyn. 2003 Sep;228(1):143-8 - PubMed
  21. Anticancer Res. 2014 Dec;34(12):6919-24 - PubMed
  22. Anticancer Res. 2005 Nov-Dec;25(6B):3855-63 - PubMed
  23. J Neurosci Res. 1996 Feb 1;43(3):315-30 - PubMed
  24. J Biol Chem. 1997 Apr 18;272(16):10769-76 - PubMed
  25. Exp Cell Res. 1995 Nov;221(1):231-40 - PubMed
  26. J Biol Chem. 2003 Feb 7;278(6):3590-8 - PubMed
  27. Dev Biol. 2010 Aug 15;344(2):1035-46 - PubMed
  28. Ann N Y Acad Sci. 2004 Dec;1028:340-50 - PubMed
  29. J Neurosci. 2007 Jul 4;27(27):7339-43 - PubMed
  30. Cancer Res. 2004 Aug 1;64(15):5481-8 - PubMed
  31. Cancer Res. 2011 Dec 15;71(24):7410-22 - PubMed
  32. Nature. 1983 Jun 2-8;303(5916):390-6 - PubMed
  33. Brain Res. 2016 May 1;1638(Pt B):167-82 - PubMed
  34. Nat Rev Neurosci. 2009 Jan;10(1):9-22 - PubMed
  35. J Neurocytol. 2002 Jul-Aug;31(6-7):437-55 - PubMed
  36. J Cell Biol. 2007 Jul 2;178(1):155-65 - PubMed
  37. J Cell Biol. 2003 Apr 14;161(1):169-86 - PubMed
  38. Angiogenesis. 2014 Jan;17(1):61-76 - PubMed
  39. J Neurosci Res. 2000 Sep 1;61(5):471-9 - PubMed
  40. Osteoarthritis Cartilage. 1998 Sep;6(5):297-305 - PubMed
  41. Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3631-2 - PubMed
  42. Glia. 2015 Aug;63(8):1429-51 - PubMed
  43. Angiogenesis. 2004;7(3):269-76 - PubMed
  44. Anticancer Res. 2015 Jan;35(1):77-84 - PubMed
  45. J Neurosci. 2009 May 20;29(20):6722-33 - PubMed
  46. Int J Nanomedicine. 2014 May 23;9:2581-95 - PubMed
  47. J Biol Chem. 1996 Oct 18;271(42):26110-6 - PubMed
  48. Development. 1991 Apr;111(4):933-44 - PubMed
  49. Cancer Lett. 2015 Sep 1;365(2):174-81 - PubMed
  50. J Cell Biochem. 2000 Aug 2;79(2):213-24 - PubMed
  51. Am J Pathol. 2001 Sep;159(3):779-86 - PubMed
  52. Cell. 2002 Apr 5;109(1):61-73 - PubMed
  53. FASEB J. 2002 Apr;16(6):586-8 - PubMed
  54. PLoS Biol. 2014 Nov 11;12 (11):e1001993 - PubMed
  55. Oncotarget. 2013 Sep;4(9):1527-46 - PubMed
  56. Cancer Cell. 2011 Sep 13;20(3):328-40 - PubMed
  57. Oncoimmunology. 2014 Jan 1;3(1):e27185 - PubMed
  58. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10361-6 - PubMed
  59. Neuropathol Appl Neurobiol. 2002 Oct;28(5):367-80 - PubMed
  60. Theranostics. 2015 Feb 15;5(5):530-44 - PubMed
  61. Cytotherapy. 2009;11(5):527-33 - PubMed
  62. J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512 - PubMed
  63. Oncotarget. 2015 May 20;6(14):12141-55 - PubMed
  64. J Anat. 1997 Feb;190 ( Pt 2):161-200 - PubMed
  65. Pigment Cell Melanoma Res. 2011 Dec;24(6):1148-57 - PubMed
  66. Am J Pathol. 2012 Mar;180(3):1145-58 - PubMed
  67. J Neurocytol. 2002 Jul-Aug;31(6-7):423-35 - PubMed
  68. PLoS One. 2011;6(7):e23062 - PubMed
  69. J Neurosci Res. 2003 Feb 1;71(3):427-44 - PubMed
  70. Cancer Res. 1999 Jun 15;59(12):2869-74 - PubMed
  71. J Neurosci. 1984 Feb;4(2):585-92 - PubMed

Publication Types